Stocks · News reference

8-K filing — Edesa Biotech, Inc. (EDSA)

2026-10-23 21:24:29 UTCSEC EDGAR

Filed: 2026-10-23 AccNo: 0001171843-26-006794 Size: 183 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

EDSA

Source: edgar
Observed: 2026-10-23 21:24:29 UTC
Checked: 2026-10-23 21:24:29 UTC
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

Fiscal.ai2026-11-05 14:04:51 UTC
Edesa Biotech to Participate in Guggenheim's 3rd Annual Healthcare Innovation Conference
Edesa Biotech, Inc. announced that its management team will participate in the Guggenheim 3rd Annual Healthcare Innovation Conference, featuring a fireside chat and investor meetings.
EDSA
Benzinga2026-10-15 13:16:34 UTCBenzinga Newsdesk
Edesa Biotech Receives FDA Clearance For Its Investigational New Drug Application For Its Phase 2 Clinical Trial Of EB06 In Vitiligo
EDSA
Benzinga2026-08-20 13:15:42 UTCBenzinga Newsdesk
Edesa Biotech shares are trading lower after the company announced the pricing of its $25 million proposed public offering of 3,870,500 shares and warrants at a $5.50 combined price.
EDSA
Benzinga2026-08-20 12:06:09 UTCBenzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-market session. The company's market cap stands at $60.1 million. The company's, Q2 earnings came out yesterday.
BIVI CIRC EDSA HYPD IVF
Benzinga2026-08-20 05:28:49 UTCBenzinga Newsdesk
Reported Earlier, Edesa Biotech Prices $25.0M Public Offering Of 3,870,500 Common Shares Plus Warrants At $5.50 Combined Price
EDSA
Benzinga2026-08-20 10:20:49 UTCAkanksha Bakshi
Edesa Biotech Stock Sinks After Fresh Capital Raise
Edesa Biotech Stock falls in premarket trading as investors weigh a $25 million offering, new warrants and potential dilution.
EDSA

8-K filing — Edesa Biotech, Inc. (EDSA)

Connected Markets

Related Headlines

Edesa Biotech to Participate in Guggenheim's 3rd Annual Healthcare Innovation Conference

Edesa Biotech Receives FDA Clearance For Its Investigational New Drug Application For Its Phase 2 Clinical Trial Of EB06 In Vitiligo

Edesa Biotech shares are trading lower after the company announced the pricing of its $25 million proposed public offering of 3,870,500 shares and warrants at a $5.50 combined price.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Reported Earlier, Edesa Biotech Prices $25.0M Public Offering Of 3,870,500 Common Shares Plus Warrants At $5.50 Combined Price

Edesa Biotech Stock Sinks After Fresh Capital Raise